• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Epidemiology of HMPV and Other Respiratory Viral Infections Among Outpatients, 2016-2022

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2026 Feb 19;13(3):ofag081.
doi: 10.1093/ofid/ofag081. eCollection 2026 Mar.
Epidemiology of HMPV and Other Respiratory Viral Infections Among Outpatients, 2016-2022

Mary Patricia Nowalk[SUP] 1 [/SUP], Monika Johnson[SUP] 2 [/SUP], Helen D'Agostino[SUP] 3 [/SUP], Gabriella Alicea[SUP] 3 [/SUP], Michael Susick[SUP] 1 [/SUP], Lora L Pless[SUP] 4 [/SUP], Richard K Zimmerman[SUP] 1 [/SUP], G K Balasubramani[SUP] 3 [/SUP], John V Williams[SUP] 5 [/SUP]


Affiliations
Abstract

Background: Most studies of human metapneumovirus (HMPV) epidemiology have been among inpatients. This study examined the epidemiology of HMPV compared with other common viruses among outpatients seeking care for an acute respiratory illness (ARI) during 5 influenza seasons (2016-2017 to 2019-2020, before the coronavirus disease 2019 pandemic, and in 2021-2022, during the pandemic).
Methods: Outpatients ≥6 months old seeking care for ARI and presenting with cough of ≤7 days' duration provided nasal and pharyngeal swab samples, demographic data, and access to electronic medical record data. Samples were tested with reverse-transcription polymerase chain reaction assays for HMPV, influenza, parainfluenza virus (PIV) 1-4, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Student's t and χ[SUP]2[/SUP] tests were used to compare HMPV cases with other ARIs.
Results: After exclusion of 68 coinfections, 7143 patients remained; 2017 had influenza, 762 had RSV, 423 had HMPV, 83 had PIV, 352 had SARS-CoV-2, and 3506 tested polymerase chain reaction negative for all of these viruses. Of all patients with ARI each influenza season, 30.2%-37.1% tested positive for influenza, 11.3%-13.6% for RSV, 4.7%-7.3% for HMPV, and 0.1%-1.9% for PIV. Compared with patients with RSV, those with HMPV less often had congestion, dyspnea, and sore throat. Compared with patients with influenza, those with HMPV were less likely to have fever but more often had congestion or dyspnea and felt worse at 7-14-day follow-up. Children recovered from HMPV faster than adults.
Conclusions: HMPV is an important cause of outpatient ARI during influenza season. Patients with HMPV had slightly different demographic characteristics and symptoms from those with other ARIs.

Keywords: HMPV; RSV; acute respiratory illness; influenza; outpatient.

 
Back
Top